Both Houses of Parliament convene after multiple adjournments, focusing on key legislation. Union Minister Anupriya will address the implementation of health recommendations, while Finance Minister Nirmala Sitharaman will present the Banking Laws (Amendment) Bill, 2024. Additionally, Railway Minister Ashwini Vaishnaw will introduce the Railways (Amendment) Bill, 2024, and Health Minister J.P. Nadda will initiate elections for AIIMS members.
10:27 29.11.2024
Reinhard Wolf, the long-serving Chairman and CEO of Raiffeisen Ware Austria (RWA), will depart from the company on November 30, 2024. Johannes Schuster, currently a member of the Board of Management, will succeed him, allowing Wolf to focus on his responsibilities at BayWa.
10:26 29.11.2024
UBS maintains a Neutral rating on Rémy Cointreau's stock with a target price of €65, following a first-half EBIT that exceeded consensus by 10%. However, the outlook for FY25 suggests a potential EBIT downgrade of 8% to 17%, with the company forecasting a 15% to 18% organic sales decline for 2024-25. The group reaffirms its long-term financial targets, aiming for a 72% gross margin and a 33% current operating margin by 2029-30.
10:24 29.11.2024
UBS maintains a Neutral rating on Remy Cointreau with a target price of €65, following the company's first half results for 2024-25, which showed EBIT 10% above consensus. However, the outlook suggests a potential EBIT downgrade of 8% to 17% for FY25, with anticipated organic sales declines of 15% to 18%. The group reaffirms its long-term financial targets for 2029-30, aiming for a gross margin of 72% and a current operating margin of 33%.
10:24 29.11.2024
The Council for Science and Technology has advised the UK Government on boosting finance for innovation in the MedTech sector, recommending reforms to pension funds, improved connections between private and public markets, and the development of specialist skills. These measures aim to enhance funding opportunities, attract talent, and support digital transformation in healthcare, ultimately unlocking access to £4.6 trillion in assets. The Chancellor is expected to adopt these recommendations to foster a more dynamic ecosystem for medical technology innovation.
UBS maintains a Neutral rating on Rémy Cointreau with a target price of €65, following a first-half EBIT that exceeded consensus by 10%. However, the outlook for FY25 suggests a potential EBIT downgrade of 8% to 17%, with the company forecasting a 15% to 18% organic sales decline for 2024-25. The group reaffirms its long-term financial targets for 2029-30, aiming for a 72% Gross Margin and a 33% Current Operating Margin.
10:20 29.11.2024
UBS has reaffirmed its opinion on Remy Cointreau's stock, as reported by Cercle Finance and published by BOURSORAMA. The analysis is provided for informational purposes only, with BOURSORAMA disclaiming any responsibility for its content and ensuring no conflicts of interest affect its objectivity.
10:20 29.11.2024
The euro is set to experience its worst month in over a year, declining approximately 3% in November to $1.0575, near a two-year low. This significant drop is attributed to concerns that US trade tariffs will further impact the already struggling European economy, marking the largest monthly decline since May 2023.
The UBS ETF - MSCI World Socially Responsible ETF A recently gained 0.22%, reaching EUR 162.86, its highest price of the day. The fund opened at EUR 162.84, with a daily turnover of 4,233 shares. On November 25, 2024, it achieved a 52-week high of EUR 164.84.
10:18 29.11.2024
The latest rich list reveals the Safra family maintaining a stable fourth place in Switzerland with assets of CHF 22.5 billion, while the Hinduja family's wealth rose to CHF 10.5 billion amid legal troubles. Martin Ebner's assets increased to CHF 3.8 billion, bolstered by his stake in Temenos, despite a share price decline. The UBP founding family is valued at CHF 2.3 billion, with notable bank managers like Sergio Ermotti and Colm Kelleher estimated around CHF 175 million.
10:18 29.11.2024

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings